Andrew G. Muntean, Ph.D. - Publications

Affiliations: 
2006 University of Chicago, Chicago, IL 
Area:
Molecular Biology, Cell Biology

27 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Melnick AF, Mullin C, Lin K, McCarter AC, Liang S, Liu YE, Wang Q, Jerome NA, Choe E, Kunnath N, Bodanapu G, Akter F, Magnuson B, Kumar S, Lombard DB, ... Muntean AG, et al. Cdc73 protects Notch-induced T-cell leukemia cells from DNA damage and mitochondrial stress. Blood. PMID 37616559 DOI: 10.1182/blood.2023020144  0.349
2022 Hu H, Saha N, Yang Y, Ahmad E, Lachowski L, Shrestha U, Premkumar V, Ropa J, Chen L, Teahan B, Grigsby S, Marschalek R, Nikolovska-Coleska Z, Muntean AG. The ENL YEATS epigenetic reader domain critically links MLL-ENL to leukemic stem cell frequency in t(11;19) Leukemia. Leukemia. PMID 36435883 DOI: 10.1038/s41375-022-01765-0  0.309
2021 Grigsby SM, Friedman A, Chase J, Waas B, Ropa J, Serio J, Shen C, Muntean AG, Maillard I, Nikolovska-Coleska Z. Elucidating the Importance of DOT1L Recruitment in MLL-AF9 Leukemia and Hematopoiesis. Cancers. 13. PMID 33562706 DOI: 10.3390/cancers13040642  0.372
2019 Ropa J, Saha N, Hu H, Peterson LF, Talpaz M, Muntean AG. SETDB1 mediated histone H3 lysine 9 methylation suppresses MLL-fusion target expression and leukemic transformation. Haematologica. PMID 31558673 DOI: 10.3324/haematol.2019.223883  0.419
2019 Saha N, Ropa J, Chen L, Hu H, Mysliwski M, Friedman A, Maillard I, Muntean AG. The PAF1c Subunit CDC73 Is Required for Mouse Hematopoietic Stem Cell Maintenance but Displays Leukemia-Specific Gene Regulation. Stem Cell Reports. PMID 31031188 DOI: 10.1016/J.Stemcr.2019.03.010  0.409
2019 Muntean AG, Ropa J, SAHA N, Hu H, Serio J, Zhao L, Basrur V, Nesvizhskii A, Maillard I. SETDB1 Mediated H3K9 Methylation Suppresses MLL-Fusion Target Expression and Leukemic Transformation Blood. 134: 110-110. DOI: 10.1182/Blood-2019-122610  0.491
2018 Ropa J, Saha N, Chen Z, Serio J, Chen W, Mellacheruvu D, Zhao L, Basrur V, Nesvizhskii AI, Muntean AG. PAF1 complex interactions with SETDB1 mediate promoter H3K9 methylation and transcriptional repression of and in acute myeloid leukemia. Oncotarget. 9: 22123-22136. PMID 29774127 DOI: 10.18632/Oncotarget.25204  0.35
2018 SAHA N, Ropa J, Chen L, Hu H, Mysliwski M, Friedman A, Maillard I, Muntean AG. The PAF1c Subunit Cdc73 Is Essential for Hematopoiesis and Displays Differential Gene Regulation in MLL-AF9 Driven Leukemia Blood. 132: 1280-1280. DOI: 10.1182/Blood-2018-99-118703  0.462
2018 Ropa J, SAHA N, Muntean AG. SETDB1 Represses Hox Gene Expression and Suppresses Acute Myeloid Leukemia Blood. 132: 1320-1320. DOI: 10.1182/blood-2018-99-117690  0.454
2017 Serio J, Ropa J, Chen W, Mysliwski M, Saha N, Chen L, Wang J, Miao H, Cierpicki T, Grembecka J, Muntean AG. The PAF complex regulation of Prmt5 facilitates the progression and maintenance of MLL fusion leukemia. Oncogene. PMID 28945229 DOI: 10.1038/onc.2017.337  0.395
2016 Chen L, Sun Y, Wang J, Jiang H, Muntean AG. Differential regulation of the c-Myc/Lin28 axis discriminates subclasses of rearranged MLL leukemia. Oncotarget. PMID 27007052 DOI: 10.18632/oncotarget.8199  0.338
2016 Serio J, Chen W, Mysliwski M, Chen L, Ropa J, Wang J, Muntean AG. The PAF Complex Regulation of Prmt5 Facilitates Leukemic Progression Blood. 128: 3914-3914. DOI: 10.1182/blood.V128.22.3914.3914  0.416
2015 Chen L, Chen W, Mysliwski M, Serio J, Ropa J, Abulwerdi FA, Chan RJ, Patel JP, Tallman MS, Paietta E, Melnick A, Levine RL, Abdel-Wahab O, Nikolovska-Coleska Z, Muntean AG. Mutated Ptpn11 alters leukemic stem cell frequency and reduces the sensitivity of acute myeloid leukemia cells to Mcl1 inhibition. Leukemia. 29: 1290-300. PMID 25650089 DOI: 10.1038/Leu.2015.18  0.428
2015 Chen L, Sun Y, Wang J, Jiang H, Muntean AG. Differential Regulation of c-Myc/Lin28 Discriminates Subclasses of Rearranged MLL Leukemia Blood. 126: 163-163. DOI: 10.1182/blood.V126.23.163.163  0.389
2014 Collins C, Wang J, Miao H, Bronstein J, Nawer H, Xu T, Figueroa M, Muntean AG, Hess JL. C/EBPα is an essential collaborator in Hoxa9/Meis1-mediated leukemogenesis. Proceedings of the National Academy of Sciences of the United States of America. 111: 9899-904. PMID 24958854 DOI: 10.1073/pnas.1402238111  0.329
2014 Chen L, Chen W, Mysliwski M, Serio J, Ropa J, Abulwerdi F, Chan RJ, Patel JP, Tallman MS, Paietta EM, Melnick AM, Levine RL, Abdel-Wahab O, Nikolovska-Coleska Z, Muntean AG. Hyperactive Ptpn11 Mutations Alters Leukemic Stem Cell Frequency through Mcl-1 Overexpression Blood. 124: 3565-3565. DOI: 10.1182/Blood.V124.21.3565.3565  0.419
2014 Rual JM, Xu T, Collins C, Zhang H, Wang J, Kuick R, Bronstein J, Basrur V, Park SS, Ha K, Chen L, Elenitoba-Johnson KS, Muntean AG, Hess JL. Characterization of the Molecular Interplay Between HOXA9 and Ogt in Leukemia Blood. 124: 3533-3533. DOI: 10.1182/blood.V124.21.3533.3533  0.447
2013 Muntean AG, Chen W, Jones M, Granowicz EM, Maillard I, Hess JL. MLL fusion protein-driven AML is selectively inhibited by targeted disruption of the MLL-PAFc interaction. Blood. 122: 1914-22. PMID 23900238 DOI: 10.1182/Blood-2013-02-486977  0.325
2012 Wang J, Muntean AG, Hess JL. ECSASB2 mediates MLL degradation during hematopoietic differentiation. Blood. 119: 1151-61. PMID 22174154 DOI: 10.1182/blood-2011-06-362079  0.405
2011 Tan J, Jones M, Koseki H, Nakayama M, Muntean AG, Maillard I, Hess JL. CBX8, a polycomb group protein, is essential for MLL-AF9-induced leukemogenesis. Cancer Cell. 20: 563-75. PMID 22094252 DOI: 10.1016/J.Ccr.2011.09.008  0.356
2010 Muntean AG, Tan J, Sitwala K, Huang Y, Bronstein J, Connelly JA, Basrur V, Elenitoba-Johnson KS, Hess JL. The PAF complex synergizes with MLL fusion proteins at HOX loci to promote leukemogenesis. Cancer Cell. 17: 609-21. PMID 20541477 DOI: 10.1016/J.Ccr.2010.04.012  0.311
2010 Wang J, Muntean AG, Hess JL. A Novel Ubiquitination Pathway Regulates MLL Activity During Hematopoietic Differentiation Blood. 116: 743-743. DOI: 10.1182/blood.v116.21.743.743  0.462
2007 Huang Z, Richmond TD, Muntean AG, Barber DL, Weiss MJ, Crispino JD. STAT1 promotes megakaryopoiesis downstream of GATA-1 in mice. The Journal of Clinical Investigation. 117: 3890-9. PMID 18060035 DOI: 10.1172/Jci33010  0.523
2007 Muntean AG, Pang L, Poncz M, Dowdy SF, Blobel GA, Crispino JD. Cyclin D-Cdk4 is regulated by GATA-1 and required for megakaryocyte growth and polyploidization. Blood. 109: 5199-207. PMID 17317855 DOI: 10.1182/Blood-2006-11-059378  0.558
2007 Muntean A, Pang L, Poncz M, Dowdy S, Blobel G, Crispino J. Cyclin D/CDK4/6 kinase activity, regulated by GATA1, is required for megakaryocyte polyploidization Blood Cells, Molecules, and Diseases. 38: 133. DOI: 10.1182/Blood.V108.11.780.780  0.586
2006 Muntean AG, Ge Y, Taub JW, Crispino JD. Transcription factor GATA-1 and Down syndrome leukemogenesis. Leukemia & Lymphoma. 47: 986-97. PMID 16840187 DOI: 10.1080/10428190500485810  0.551
2005 Muntean AG, Crispino JD. Differential requirements for the activation domain and FOG-interaction surface of GATA-1 in megakaryocyte gene expression and development. Blood. 106: 1223-31. PMID 15860665 DOI: 10.1182/Blood-2005-02-0551  0.57
Show low-probability matches.